224 related articles for article (PubMed ID: 34923027)
1. Interleukin-1 signaling in solid organ malignancies.
Dosch AR; Singh S; Nagathihalli NS; Datta J; Merchant NB
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188670. PubMed ID: 34923027
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
Voronov E; Apte RN
Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies.
Zarezadeh Mehrabadi A; Shahba F; Khorramdelazad H; Aghamohammadi N; Karimi M; Bagherzadeh K; Khoshmirsafa M; Massoumi R; Falak R
Crit Rev Oncol Hematol; 2024 Jan; 193():104200. PubMed ID: 37981104
[TBL] [Abstract][Full Text] [Related]
4. Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.
Liu F; Li L; Lan M; Zou T; Kong Z; Cai T; Wu XY; Cai Y
Mediators Inflamm; 2021; 2021():7785890. PubMed ID: 34602858
[TBL] [Abstract][Full Text] [Related]
5. IL-1 and IL-1 regulatory pathways in cancer progression and therapy.
Mantovani A; Barajon I; Garlanda C
Immunol Rev; 2018 Jan; 281(1):57-61. PubMed ID: 29247996
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer.
Ray K; Ujvari B; Ramana V; Donald J
Cytokine Growth Factor Rev; 2018 Jun; 41():18-27. PubMed ID: 29680500
[TBL] [Abstract][Full Text] [Related]
7. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.
Rostami N; Nikkhoo A; Ajjoolabady A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Yousefi B; Yousefi M; Jadidi-Niaragh F
Mol Diagn Ther; 2019 Aug; 23(4):467-487. PubMed ID: 31115798
[TBL] [Abstract][Full Text] [Related]
8. The role of interleukin-17 in tumor development and progression.
Zhao J; Chen X; Herjan T; Li X
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727782
[TBL] [Abstract][Full Text] [Related]
9. Dual role of IL-37 in the progression of tumors.
Zhu Y; Qin H; Ye K; Sun C; Qin Y; Li G; Wang H; Wang H
Cytokine; 2022 Feb; 150():155760. PubMed ID: 34800851
[TBL] [Abstract][Full Text] [Related]
10. IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
Karakasheva TA; Lin EW; Tang Q; Qiao E; Waldron TJ; Soni M; Klein-Szanto AJ; Sahu V; Basu D; Ohashi S; Baba K; Giaccone ZT; Walker SR; Frank DA; Wileyto EP; Long Q; Dunagin MC; Raj A; Diehl JA; Wong KK; Bass AJ; Rustgi AK
Cancer Res; 2018 Sep; 78(17):4957-4970. PubMed ID: 29976575
[TBL] [Abstract][Full Text] [Related]
11. Targeting the microenvironment in solid tumors.
Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.
Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K
Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671
[TBL] [Abstract][Full Text] [Related]
13. Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review).
Zhang X; Meng T; Cui S; Liu D; Pang Q; Wang P
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616129
[TBL] [Abstract][Full Text] [Related]
14. Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies.
Gelfo V; Romaniello D; Mazzeschi M; Sgarzi M; Grilli G; Morselli A; Manzan B; Rihawi K; Lauriola M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825489
[TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-7 Signaling in the Tumor Microenvironment.
Bednarz-Misa I; Bromke MA; Krzystek-Korpacka M
Adv Exp Med Biol; 2021; 1290():9-49. PubMed ID: 33559853
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
17. The Role of IL-33/ST2 Pathway in Tumorigenesis.
Larsen KM; Minaya MK; Vaish V; Peña MMO
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
[TBL] [Abstract][Full Text] [Related]
18. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
20. IL-36 Signaling in the Tumor Microenvironment.
Chelvanambi M; Weinstein AM; Storkus WJ
Adv Exp Med Biol; 2020; 1240():95-110. PubMed ID: 32060891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
